US equities
|
MU
$989.04
▲+0.00%
SNDK
$1,487.33
▲+0.00%
NVDA
$226.32
▲+0.00%
SKHY
$162.23
▲+0.00%
JPM
$334.30
▲+0.00%
GS
$893.95
▲+0.00%
INTC
$101.35
▲+0.00%
META
$742.96
▲+0.00%
MU
$989.04
▲+0.00%
SNDK
$1,487.33
▲+0.00%
NVDA
$226.32
▲+0.00%
SKHY
$162.23
▲+0.00%
JPM
$334.30
▲+0.00%
GS
$893.95
▲+0.00%
INTC
$101.35
▲+0.00%
META
$742.96
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
OptimizeRx Corporation - Common Stock
(NQ:
OPRX
)
8.220
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about OptimizeRx Corporation - Common Stock
< Previous
1
2
3
4
Next >
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
September 22, 2026
Expands programmatic access to 800,000 verified prescribers directly in the EHR workflow, making OptimizeRx’s point of care inventory directly available to advertisers using The Trade Desk
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
September 14, 2026
New functionality helps DSPs and agency planners create deterministic HCP and consumer audiences faster, using one single workflow
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
September 08, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
September 02, 2026
Experienced pharmaceutical and healthcare executive joins advisory board to help accelerate innovation and strengthen life sciences marketing technology
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
August 12, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
August 12, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
July 29, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
July 23, 2026
Leading pharmaceutical marketing executive joins leadership team to accelerate innovation and strengthen partnerships across the life sciences industry
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
June 30, 2026
Enhanced technology delivers brand savings offers directly within the prescribing workflow, when HCP intent is highest
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
June 25, 2026
Patent-pending, embeddable NLAB technology enables pharma and agency marketers to build custom, verified HCP audiences using natural-language prompts
From
OptimizeRx Corporation
Via
GlobeNewswire
MissionIRNewsBreaks – OptimizeRx Corp. (NASDAQ: OPRX) Secures $35 Million Senior Credit Facility
June 11, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
OptimizeRx to Participate in Upcoming Investor Conferences
June 01, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
May 21, 2026
Powered by OptimizeRx’s new programmatic infrastructure, collaboration expands access to premium point of care inventory for life sciences marketers
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
May 12, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
May 11, 2026
Expands life sciences marketers’ reach at the validated point of care, enabling DSPs to directly integrate with OptimizeRx’s trusted EHR network for the first time
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
April 29, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
April 28, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
February 05, 2026
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
January 07, 2026
Life science marketers will be able to better measure the exposed audiences for a more complete, accurate, and transparent view of campaign engagement and effectiveness
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
December 17, 2025
Strategic Partnerships Add Exclusivity in Leading EHR, e-Prescription, and Technology Companies, Increasing NPI Reach by 37%
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
November 06, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
October 20, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
September 10, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
September 09, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
August 19, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
August 07, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
July 17, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
June 24, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
